SUBSCRIBE to our newsletter
Possibly coming soon! New RNS device. Past 1 portion of FDA panels. 53% improvement after
We are excited to introduce you to George Choyce who has epilepsy, and has agreed to write a new monthly column -- Fresh Callings -- for our newsletter!
A New Epilepsy Drug is Now Approved: Oxtellar XR™ is the first and only FDA-approved once-daily oxcarbazepine product and will be available in the first quarter 2013.
We will need a few volunteers very soon.